Motilal Oswal: Jyothy Labs’ Q2 Performance Above Expectations; Near-Term Outlook Attractive
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Jyothy Laboratories Ltd. reported better-than-expected numbers in Q2 FY21.
The outlook also appears good for the next couple of quarters, supported by
- continued tailwinds in the dishwashing and household Insecticides categories,
- 40% sales contribution coming from rural (which is likely to fare even better in H2 FY21), and
- a highly favorable base in the two remaining quarters ( versus sales decline of 6.2% YoY in Q3 FY20 and 24.2% in Q4 FY20).
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.